Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Emmanouil Zerdevas of Greece, Ioannis Fountoulis of Greece during the... News Photo - Getty Images
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Ioannis Zerdes - Glifádha, Attiki, Greece | Professional Profile | LinkedIn
Tumor-infiltrating lymphocytes and the PD-L1/PD-1 signaling axis in breast cancer: biology and clinical implications | Semantic Scholar
111 Ioannis Fountoulis Photos and Premium High Res Pictures - Getty Images
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
TOKYO, JAPAN - AUGUST 8: Silver for team Greece with head coach Theodoros Vlachos of Greece, Emmanouil Zerdevas of Greece, Konstantinos Genidounias of Greece, Dimitrios Skoumpakis of Greece, Marios Kapotsis of Greece,
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Editorial Board | ARC Journal of Cancer Science | High Impact Journals
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
TOKYO, JAPAN - AUGUST 2: Angelos Vlachopoulos of Greece, Konstantinos Gkiouvetsis of Greece, Christodoulos Kolomvos of Greece, Konstantinos Mourikis of Greece, Stylianos Argyropoulos of Greece, Georgios Dervisis of Greece, Alexandros Papanastasiou of
Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer
